No, that's rather simplistic.
It would more so be about the effects of psilocybin on specific regions of the nervous system such as the sympathetic nerves and it would involve methods like sympathetic microneurography and comparisons of activity between a control group and a group with psilocybin administered. That's what lab mice are for and though the ethical and legal constrains seem a great hurdle there is some effort for the recognition of the importance of such studies with legalisation likely to be on the ballot in California in 2018.
Quote: The sympathetic nervous system plays important roles in the beat-to-beat control of blood pressure, the control of blood flow through various organs and the maintenance of core temperature through thermoregulatory processes. The development of microneurography, in which nerve activity can be recorded directly from intraneural microelectrodes inserted percutaneously into a peripheral nerve in awake human subjects, has provided a wealth of information on the control of sympathetic outflow to muscle and skin. Although not intended to be diagnostic, recordings of muscle sympathetic nerve activity (MSNA) and skin sympathetic nerve activity (SSNA) in different disease states have increased our understanding of the operation of the sympathetic nervous system. And while quantification of sympathetic nerve activity is still largely limited to measures of burst frequency (bursts/minute) and burst incidence (bursts/100 heart beats), the development of single-unit recordings of MSNA and SSNA have provided more detailed information on how the sympathetic nervous system grades its output. This chapter reviews the development of sympathetic microneurography and its application in health and disease.
https://www.ncbi.nlm.nih.gov/pubmed/24095138
Even so there's no real need because there's already quite a substantial amount of work already done on what psilocybin does to the body and how it effects the nervous system.
etc, etc, etc.
Quote: “Characteristic autonomic effects of the neurovegetative system that were notable for the whole animal excitatory syndrome caused by the central stimulation of the sympathetic nervous system.”
doczz.net/doc/338366/the-pharmacology-of-psilocybin http://www.maps.org/research-archive/w3pb/2002/2002_Passie_22704_1.pdf
Quote: Behavioural effects are dependent on dose and the individual reaction and sensitivity to psilocybin, previous experiences and the setting. The major effects are related to the central nervous system, but there are also some sympathomimetic effects.
Psilocin mainly interacts with 5-HT1A, 5-HT2A and 5-HT2C receptor subtypes: it is a mixed receptor agonist. In contrast to LSD, psilocin does not have an effect on the dopamine receptor. Tryptamines and phenethylamine hallucinogens both have a relatively high affinity for serotonin 5-HT2 receptors, but they differ in their affinity for other subtypes of serotonin receptors.
EMCDDA | Hallucinogenic mushrooms profile (chemistry, effects, other names (magic mushrooms, shrooms…), origin, mode of use, other names, medical use, control status). (2015). Emcdda.europa.eu. Retrieved 12 April 2017, from http://www.emcdda.europa.eu/publications/drug-profiles/mushrooms
Quote: Psilocin has a high affinity for the 5-HT2A serotonin receptor in the brain, where it mimics the effects of serotonin (5-hydroxytryptamine, or 5-HT). Psilocin binds less tightly to other serotonergic receptors 5-HT1A, 5-HT1D, and 5-HT2C.
European Molecular Biology Laboratory, chebi:8614 psilocybin. (2014). Myhits.isb-sib.ch. Retrieved 12 April 2017, from http://myhits.isb-sib.ch/cgi-bin/view_cla_entry?name=chebi:8614&cla_view_chebi=ChEBI
Basically the active ingredients in psychoactive fungi are suggested to work on the human nervous system through sympathomimetic actions down serotonergic pathways from 5-HT receptors. Unironically the serotonergic pathways effect the sympathetic nerves and this suggests a correlation with the HPA Axis, though correlation doesn't necessarily mean cause, necessarily.
Quote: Several tissues, organs, and neural circuits contribute to the control of blood pressure, and 5-HT can influence many of them. Table 1 lists the relevant locations of the various 5-HT receptors that contribute to cardiovascular regulation. Although we will briefly describe 5-HT's effects in the kidney, adrenal gland, heart, and blood, the focus of this review is on the vasculature, its control by the sympathetic nervous system, and the central nervous system pathways that determine the sympathetic nerve activity to cardiovascular tissues.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310484/
Quote: The dynamic interplay between serotonin [5-hydroxytryptamine (5-HT)] neurotransmission and the hypothalamic–pituitary–adrenal (HPA) axis has been extensively studied over the past 30 years, but the underlying mechanism of this interaction has not been defined. A possibility receiving little attention is that 5-HT regulates upstream corticotropin-releasing hormone (CRH) signaling systems via activation of serotonin 2C receptors (5-HT2CRs) in the paraventricular nucleus of the hypothalamus (PVH). Through complementary approaches in wild-type rodents and 5-HT2CR-deficient mice, we determined that 5-HT2CRs are necessary for 5-HT-induced HPA axis activation.
http://www.jneurosci.org/content/27/26/6956
What I would be interest in is a paper that says psilocybin does not have an influence on sympathetic nerves, because the view I've taken hypothesises the physical experience of stimulating the sympathetic nerves with psilocybin can help with overcoming the fight or flight response by influencing the HPA Axis to reduce heart rate and blood pressure via the suppression of the release of stress hormones.
Even so again I doubt you'll bother to connect the dots yourself, I hope you will but it's not an expectation.
-------------------- I am whatever Darwin needs me to be.
|